Order Article Reprints

Cai L, Rogers TJ, Mousavi Jafarabad R, Vu H, Yang C, Novaresi N, Galán-Cobo A, Girard L, Ostrin EJ, Fahrmann JF, et al.  High KYNU Expression Is Associated with Poor Prognosis, KEAP1/STK11 Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung Adenocarcinomas. Cancers. 2025; 17(10):1681. https://doi.org/10.3390/cancers17101681

Cai, Ling, Thomas J. Rogers, Reza Mousavi Jafarabad, Hieu Vu, Chendong Yang, Nicole Novaresi, Ana Galán-Cobo, Luc Girard, Edwin J. Ostrin, Johannes F. Fahrmann, and et al. 2025. " High KYNU Expression Is Associated with Poor Prognosis, KEAP1/STK11 Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung Adenocarcinomas" Cancers 17, no. 10: 1681. https://doi.org/10.3390/cancers17101681

Cai, L., Rogers, T. J., Mousavi Jafarabad, R., Vu, H., Yang, C., Novaresi, N., Galán-Cobo, A., Girard, L., Ostrin, E. J., Fahrmann, J. F., Kim, J., Heymach, J. V., O’Donnell, K. A., Xiao, G., Xie, Y., DeBerardinis, R. J., & Minna, J. D. (2025).  High KYNU Expression Is Associated with Poor Prognosis, KEAP1/STK11 Mutations, and Immunosuppressive Metabolism in Patient-Derived but Not Murine Lung Adenocarcinomas. Cancers, 17(10), 1681. https://doi.org/10.3390/cancers17101681